Concepedia

Michelle Fodor

MF

13

Publications

2.1K

Citations

13

H-Index

2016

Active since

Affiliations

Novartis (United States)(Current)

Harvard University

Dana-Farber Cancer Institute

Novartis (Switzerland)

Michelle Fodor is an author at Novartis (United States) specializing in medicine, natural sciences, and drug discovery.

Top concepts

Publications per year

2016–2025

13

Publications

13

Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases

Ying-Nan P. Chen, Matthew J. LaMarche, Ho Man Chan et al. · Nature · 2016 · 893 citations

, , +12

Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor

Jorge Fortanet, Christine Hiu-Tung Chen, Ying-Nan P. Chen et al. · Journal of Medicinal Chemistry · 2016 · 284 citations · Full text

, , +20

Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer

Matthew J. LaMarche, Michael Acker, Andreea Argintaru et al. · Journal of Medicinal Chemistry · 2020 · 207 citations · Full text

Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition

Jonathan R. LaRochelle, Michelle Fodor, Vidyasiri Vemulapalli et al. · Nature Communications · 2018 · 162 citations · Full text

Dual Allosteric Inhibition of SHP2 Phosphatase

Michelle Fodor, Edmund V. Price, Ping Wang et al. · ACS Chemical Biology · 2018 · 127 citations · Full text

Rows per page

1–5 of 13